US regulators lift in-person restrictions on abortion pill
Officials said Thursday that a scientific review supported broadening access and allowing more pharmacies - including mail-order services- to distribute the medication.
Share:
More Stories
1:37
Storm Watch Team Meteorologist Skyler Harman strikes down lightning myths
49m ago1:43
Lead found on Keyport beach not ‘urgent risk’ to public health, no need to close beach
1h ago3:00
Beautiful weekend ahead for New Jersey with sunny skies and warm temperatures
2h ago0:55
EPA completes Phase 1 of superfund site cleanup at Unimatic Manufacturing site in Fairfield
2h ago0:20
West New York school named for Sen. Menendez to revert to original name
2h ago2:16
Fire at Fair Lawn strip mall destroys multiple businesses, including popular Zadies Bakery
2h ago1:37
Storm Watch Team Meteorologist Skyler Harman strikes down lightning myths
49m ago1:43
Lead found on Keyport beach not ‘urgent risk’ to public health, no need to close beach
1h ago3:00
Beautiful weekend ahead for New Jersey with sunny skies and warm temperatures
2h ago0:55
EPA completes Phase 1 of superfund site cleanup at Unimatic Manufacturing site in Fairfield
2h ago0:20
West New York school named for Sen. Menendez to revert to original name
2h ago2:16
Fire at Fair Lawn strip mall destroys multiple businesses, including popular Zadies Bakery
2h agoThe Food and Drug Administration is loosening some restrictions on where women can obtain abortion pills, including a long-standing requirement that the medication be picked up in person.
Officials said Thursday that a scientific review supported broadening access and allowing more pharmacies - including mail-order services- to distribute the medication.
But prescribing will still be limited to doctors who complete special certification. Additionally, the agency said dispensing pharmacies will have to be registered with the agency.
The decision is the latest shift in the polarized legal battle over medication abortion, which has only intensified amid the disruptions of the COVID-19 pandemic.
It is certain to spur legal challenges and restrictions in Republican-led states amid the ongoing battle over abortion.
Earlier this the year the FDA stopped enforcing the in-person dispending requirement because of the pandemic. Under Thursday’s decision, the agency will permanently drop the rule, which has long been opposed by medical societies and pro-abortion groups.
